The combination of the low immunohistochemical expression of peroxiredoxin 4 and perilipin 2 predicts longer survival in pancreatic ductal adenocarcinoma with peroxiredoxin 4 possibly playing a main role.

Jia Han, Sohsuke Yamada, Takeru Oyama et al.|PubMed|2023

Cited by 6